Term
|
Definition
Dilantin®
Sodium Channel Blocking Agent |
|
|
Term
|
Definition
Tegretol®
Sodium Channel Blocking Agent |
|
|
Term
|
Definition
Lamictal®
Sodium Channel Blocking Agent |
|
|
Term
|
Definition
Topamax®
Sodium Channel Blocking Agent & Glutamate Receptor Antagonist (NMDA, AMPA, Kainic Acid) |
|
|
Term
|
Definition
Zonegran®
Sodium Channel Blocking Agent |
|
|
Term
|
Definition
Depakote®
Sodium Channel Blocking Agent & T-calcium Channel Blockers |
|
|
Term
|
Definition
Trileptal®
Sodium Channel Blocking Agent |
|
|
Term
|
Definition
Lyrica®
Sodium Channel Blocking Agent |
|
|
Term
|
Definition
Vipmat®
Sodium Channel Blocking Agent |
|
|
Term
|
Definition
Luminal®
Enhancement of GABA & Glutamate Receptor Antagonism (NMDA, AMPA, Kainic Acid) |
|
|
Term
|
Definition
Klonopin®
Enhancement of GABA |
|
|
Term
|
Definition
Ativan®
Enhancement of GABA |
|
|
Term
|
Definition
Valium®
Enhancement of GABA |
|
|
Term
|
Definition
Sabril®
Enhancement of GABA |
|
|
Term
|
Definition
Neurontin®
Enhancement of GABA & Idiopathic Agents (Unknown Mechanism of Action) |
|
|
Term
|
Definition
Gabitril®
Enhancement of GABA |
|
|
Term
|
Definition
Mysoline®
Enhancement of GABA |
|
|
Term
|
Definition
Felbatol®
Glutamate Receptor Antagonism (NMDA, AMPA, Kainic Acid) & Idiopathic Agents (Unknown Mechanism) |
|
|
Term
|
Definition
Zarontin®
T-calcium Channel Blocker |
|
|
Term
|
Definition
Keppra®
Idiopathic Agents (Unknown Mechanism of Action) |
|
|
